As per the German Cancer Study Group’s indications, TSS could be a potential choice for select patients with malignant tumors in a solitary testis or bilateral tumors, provided that the lesion’s diameter is less than 2 cm, there is no invasion of the rete testis, and the preoperative serum luteinizing hormone (LH) levels are normal. This evidence concerns the gene PLOD1 and cancer.